RYTM Financials
Rhythm Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$104.74
Market Cap
$6.49B
P/E Ratio
-24.1
EPS
$-4.34
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$130.13M
Gross Profit
-
Operating Income
-
Net Income
$-260.60M
EPS (Diluted)
$-4.34
Balance Sheet Highlights
Total Assets
$392.27M
Total Liabilities
$227.72M
Shareholders Equity
-
Cash & Equivalents
$89.14M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-113.88M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-93.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RYTM revenue?
RYTM's most recent quarterly revenue was $130.13M. Annual revenue can be calculated by summing the four most recent quarters.
Is RYTM profitable?
RYTM reported a loss of $260.60M in the most recent quarter. The net profit margin is -93.3%.
What is RYTM market cap?
RYTM has a market capitalization of $6.49B, making it a mid-cap stock.
Does RYTM have debt?
View RYTM's balance sheet for debt information.
What is RYTM cash flow?
Cash flow data is available in the full financial statements.